ERCC1 and Thymidylate Synthase mRNA Levels Predict Survival for Colorectal Cancer Patients Receiving Combination Oxaliplatin and Fluorouracil Chemotherapy
作者： Yoshinori Shirota , Jan Stoehlmacher , Jan Brabender , Yi-Ping Xiong , Hiroyuki Uetake
DOI: 10.1200/JCO.2001.19.23.4298
关键词:
摘要: PURPOSE: To test the hypotheses of whether the relative mRNA expression of the thymidylate synthase (TS) gene and the excision cross-complementing (ERCC1) gene are …
sci-hub.se 参考文章(33)
Harry Bleiberg, Role of chemotherapy for advanced colorectal cancer: new opportunities. Seminars in Oncology. ,vol. 23, pp. 42- 50 ,(1996)
T.A. Dunn, H.J. Schmoll, V. Grünwald, V. Bokemeyer, J. Casper, Comparative cytotoxicity of oxaliplatin and cisplatin in non-seminomatous germ cell cancer cell lines. Investigational New Drugs. ,vol. 15, pp. 109- 114 ,(1997) , 10.1023/A:1005800520747
Carol L. MacLeod, Sibylle Nebel, Randolph D. Christen, Paula S. Norris, Tzu-Ping Lin, Stefan Aebi, Stephen B. Howell, Martin Haas, Hua Zheng, Alissar Nehmé, Daniel Fink, In Vitro and in Vivo Resistance to Cisplatin in Cells That Have Lost DNA Mismatch Repair Cancer Research. ,vol. 57, pp. 1841- 1845 ,(1997)
H J Lenz, C G Leichman, K D Danenberg, P V Danenberg, S Groshen, H Cohen, L Laine, P Crookes, H Silberman, J Baranda, Y Garcia, J Li, L Leichman, Thymidylate synthase mRNA level in adenocarcinoma of the stomach: a predictor for primary tumor response and overall survival. Journal of Clinical Oncology. ,vol. 14, pp. 176- 182 ,(1996) , 10.1200/JCO.1996.14.1.176
R Metzger, C G Leichman, K D Danenberg, P V Danenberg, H J Lenz, K Hayashi, S Groshen, D Salonga, H Cohen, L Laine, P Crookes, H Silberman, J Baranda, B Konda, L Leichman, ERCC1 mRNA levels complement thymidylate synthase mRNA levels in predicting response and survival for gastric cancer patients receiving combination cisplatin and fluorouracil chemotherapy. Journal of Clinical Oncology. ,vol. 16, pp. 309- 316 ,(1998) , 10.1200/JCO.1998.16.1.309
B. Florentine, P. V. Danenberg, H.-J. Lenz, S. Groshen, K. D. Danenberg, P. G. Johnston, Linyun Zhou, C. G. Leichman, L. P. Leichman, Yi Ping Xiong, p53 and thymidylate synthase expression in untreated stage II colon cancer: associations with recurrence, survival, and site. Clinical Cancer Research. ,vol. 4, pp. 1227- 1234 ,(1998)
Sibylle Nebel, Randolph D. Christen, Stefan Aebi, Stephen B. Howell, Hua Zheng, Bruno Cenni, Alissar Nehmé, Daniel Fink, The role of DNA mismatch repair in platinum drug resistance. Cancer Research. ,vol. 56, pp. 4881- 4886 ,(1996)
E. Reed, Platinum-DNA adduct, nucleotide excision repair and platinum based anti-cancer chemotherapy. Cancer Treatment Reviews. ,vol. 24, pp. 331- 344 ,(1998) , 10.1016/S0305-7372(98)90056-1
M.A Bensmaı̈ne, A de Gramont, S Brienza, M Marty, F Lévi, M Ducreux, E François, E Gamelin, H Bleiberg, P Bleuzen, J Simon, E Cvitkovic, Factors predicting for efficacy of oxaliplatin in combination with 5-fluorouracil (5-FU)+/-folinic acid (FA) in a compassionate-use cohort of 370 5-FU-resistant advanced colorectal cancer (CRC) patients. European Journal of Cancer. ,vol. 36, pp. 2335- 2343 ,(2000) , 10.1016/S0959-8049(00)00305-1
Alan E Tomkinson, A. Jane Bardwell, Lee Bardwell, Nancy J. Tappe, Errol C. Friedberg, Yeast DNA repair and recombination proteins Rad1 and Rad10 constitute a single-stranded-DNA endonuclease Nature. ,vol. 362, pp. 860- 862 ,(1993) , 10.1038/362860A0